<?xml version="1.0"?>
<!DOCTYPE Article PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Article ID="s00066-014-0711-4" OutputMedium="All">
  
  
  
  
  <ArticleInfo Language="En" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" TocLevels="0" ContainsESM="No">
  <ArticleID>711</ArticleID>
  <ArticleDOI>10.1007/s00066-014-0711-4</ArticleDOI>
  <ArticleSequenceNumber>0</ArticleSequenceNumber>
  <ArticleTitle Language="En">Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU</ArticleTitle>
  <ArticleSubTitle Language="En">More than 20 years’ experience at a single institution</ArticleSubTitle>
  <ArticleTitle Language="De">Langzeitergebnisse der trimodalen Therapie des Ösophagusplattenepithelkarzinoms mit Cisplatin und/oder 5-FU</ArticleTitle>
  <ArticleSubTitle Language="De">Mehr als 20 Jahre Erfahrung an einem einzigen Institut</ArticleSubTitle>
  <ArticleCategory>Original article</ArticleCategory>
  <ArticleFirstPage>1</ArticleFirstPage>
  <ArticleLastPage>1</ArticleLastPage>
  <ArticleHistory>
    <RegistrationDate>
      <Year>2014</Year>
      <Month>6</Month>
      <Day>9</Day>
    </RegistrationDate>
    <Received>
      <Year>2014</Year>
      <Month>5</Month>
      <Day>8</Day>
    </Received>
    <Accepted>
      <Year>2014</Year>
      <Month>6</Month>
      <Day>9</Day>
    </Accepted>
    <OnlineDate>
      <Year>
        <?InsertOnReleaseOF OFYear?>
      </Year>
      <Month>
        <?InsertOnReleaseOF OFMonth?>
      </Month>
      <Day>
        <?InsertOnReleaseOF OFDay?>
      </Day>
    </OnlineDate>
  </ArticleHistory>
  <ArticleCopyright>
    <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
    <CopyrightYear>2014</CopyrightYear>
  </ArticleCopyright>
  <ArticleContext>
    <JournalID>66</JournalID>
    <VolumeIDStart>
      <?InsertByIssueBuilding VolumeIDStart?>
    </VolumeIDStart>
    <VolumeIDEnd>
      <?InsertByIssueBuilding VolumeIDEnd?>
    </VolumeIDEnd>
    <IssueIDStart>
      <?InsertByIssueBuilding IssueIDStart?>
    </IssueIDStart>
    <IssueIDEnd>
      <?InsertByIssueBuilding IssueIDEnd?>
    </IssueIDEnd>
  </ArticleContext>
</ArticleInfo>
  <ArticleHeader>
    <AuthorGroup>
      <?oxy_comment_start comment="Author had made changes in author name. Please check."?><Author CorrespondingAffiliationID="Aff10" AffiliationIDS="Aff1 Aff2 Aff10"><AuthorName><GivenName>Khashayar</GivenName><FamilyName>Fakhrian</FamilyName><Degrees>M.D.</Degrees></AuthorName><Contact><Phone>(+) 49 (0)2323 499-1531</Phone><Email>khfmed@yahoo.com</Email></Contact></Author><?oxy_comment_end?>
      <Author AffiliationIDS="Aff2"><AuthorName><GivenName>Arif Deniz</GivenName><FamilyName>Ordu</FamilyName><Degrees>M.D.</Degrees></AuthorName></Author>
      <Author AffiliationIDS="Aff3 Aff4"><AuthorName><GivenName>Florian</GivenName><FamilyName>Lordick</FamilyName><Degrees>M.D.</Degrees></AuthorName></Author>
      <Author AffiliationIDS="Aff5"><AuthorName><GivenName>Jörg</GivenName><FamilyName>Theisen</FamilyName><Degrees>M.D.</Degrees></AuthorName></Author>
      <Author AffiliationIDS="Aff6"><AuthorName><GivenName>Bernhard</GivenName><FamilyName>Haller</FamilyName></AuthorName></Author>
      <Author AffiliationIDS="Aff2 Aff7"><AuthorName><GivenName>Tomislav</GivenName><FamilyName>Omrčen</FamilyName><Degrees>M.D.</Degrees></AuthorName></Author>
      <Author AffiliationIDS="Aff2"><AuthorName><GivenName>Michael</GivenName><FamilyName>Molls</FamilyName><Degrees>M.D.</Degrees></AuthorName></Author>
      <Author AffiliationIDS="Aff8 Aff11"><AuthorName><GivenName>Carsten</GivenName><FamilyName>Nieder</FamilyName><Degrees>M.D.</Degrees></AuthorName></Author>
      <Author AffiliationIDS="Aff2 Aff9"><AuthorName><GivenName>Hans</GivenName><FamilyName>Geinitz</FamilyName><Degrees>M.D.</Degrees></AuthorName></Author>
      <Affiliation ID="Aff1">
        
        <OrgDivision>Department of Radiation Oncology, Marienhospital Herne</OrgDivision>
        <OrgName>Universitätsklinikum der Ruhr-Universität Bochum</OrgName>
        <OrgAddress>
          <City>Bochum</City>
          <Country>Germany</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff2">
        
        <OrgDivision>Department of Radiation Oncology, Klinikum rechts der Isar</OrgDivision>
        <OrgName>Technische Universität München</OrgName>
        <OrgAddress>
          <City>Munich</City>
          <Country>Germany</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff3">
        
        <OrgDivision>University Cancer Center Leipzig (UCCL)</OrgDivision>
        <OrgName>University Clinic Leipzig</OrgName>
        <OrgAddress>
          <City>Leipzig</City>
          <Country>Germany</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff4">
        
        <OrgDivision>Department of Internal Medicine III (Hematology/Oncology)</OrgDivision>
        <OrgName>Technische Universität München</OrgName>
        <OrgAddress>
          <City>Munich</City>
          <Country>Germany</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff5">
        
        <OrgDivision>Department of Surgery, Klinikum rechts der Isar</OrgDivision>
        <OrgName>Technische Universität München</OrgName>
        <OrgAddress>
          <City>Munich</City>
          <Country>Germany</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff6">
        
        <OrgDivision>Institute for Medical Statistics and Epidemiology, Klinikum rechts der Isar</OrgDivision>
        <OrgName>Technische Universität München</OrgName>
        <OrgAddress>
          <City>Munich</City>
          <Country>Germany</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff7">
        
        <OrgDivision>Center of Oncology and Radiotherapy</OrgDivision>
        <OrgName>University Hospital Split</OrgName>
        <OrgAddress>
          <City>Split</City>
          <Country>Croatia</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff8">
        
        <OrgDivision>Department of Oncology and Palliative Medicine</OrgDivision>
        <OrgName>Nordland Hospital Trust</OrgName>
        <OrgAddress>
          <City>Bodø</City>
          <Country>Norway</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff9">
        
        <OrgDivision>Department of Radiation Oncology</OrgDivision>
        <OrgName>Krankenhaus der Barmherzigen Schwestern Linz</OrgName>
        <OrgAddress>
          <City>Linz</City>
          <Country>Austria</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff10">
        
        <OrgDivision>Klinik für Strahlentherapie und Radio-Onkologie, Marienhospital Herne</OrgDivision>
        <OrgName>Universitätsklinikum der Ruhr-Universität Bochum</OrgName>
        <OrgAddress>
          <Street>Hölkeskampring 40</Street>
          <Postcode>44625</Postcode>
          <City>Herne</City>
          <Country>Germany</Country>
        </OrgAddress>
      </Affiliation>
      <Affiliation ID="Aff11">
        
        <OrgDivision>Institute of Clinical Medicine, Faculty of Health Sciences</OrgDivision>
        <OrgName>University of Tromsø</OrgName>
        <OrgAddress>
          <City>Tromsø</City>
          <Country>Norway</Country>
        </OrgAddress>
      </Affiliation>
    </AuthorGroup>
    <Abstract ID="Abs1" Language="En" OutputMedium="All">
      <Heading>Abstract</Heading>
      <AbstractSection ID="ASec1">
        <Heading>Purpose</Heading>
        <Para>The purpose of this article is to report the outcome of neoadjuvant radiochemotherapy (N-RCT) + surgery in patients with squamous cell carcinoma of the esophagus at a single institution.</Para>
      </AbstractSection>
      <AbstractSection ID="ASec2">
        <Heading>Methods</Heading>
        <Para>We retrospectively reviewed data from patients who were referred to our department for N-RCT. From 1988–2011, 103 patients were treated with N-RCT with cisplatin and/or 5-fluorouracil (5-FU). Group 1: (n = 55) from 1988–2006 with 39.6–40 Gy and 5-FU with (n = 17) or without cisplatin (n = 38). Group 2: from 2003–2010 with 44–45 Gy and 5-FU with (n = 40) or without cisplatin (n = 8). All patients underwent radical resection with reconstruction according to tumor location and 2-field lymph node dissection. The degree of histomorphologic regression was defined as grade 1a (pCR, 0 % residual tumor), grade 1b (pSTR, &lt; 10 % residual tumor), grade 2 (10–50 % residual tumor), and grade 3 (&gt; 50 % residual tumor).</Para>
      </AbstractSection>
      <AbstractSection ID="ASec3">
        <Heading>Results</Heading>
        <Para>Median follow-up time from the start of N-RCT was 100 months (range 2–213 months). The median overall survival (OS) for the whole cohort was 42 months and the 5-year OS was 45 ± 5 %. In the multivariate analysis, worse ECOG performance status (p &lt; 0.001), weight loss &gt; 10 % before the start of the N-RCT (p = 0.025), higher pT category (p = 0.001), and grade 2/3 pathologic remission (p &lt; 0.001) were significantly associated with a poor OS. PCR and pSTR rates for group 1 were 36 % and 18 % compared to 53 % and 22 % for group 2 (p = 0.011). There was a tendency for a better outcome in group 2 patients without statistical significance. The 5-year OS, disease-free survival and recurrent-free survival were 36 ± 7 %, 35 ± 6, and 36 ± 7 % for group 1 and 55 ± 7, 49 ± 7, and 53 ± 7 in group 2 (p = 0.117, p = 0.124, and p = 0.087). There was no significant difference between the two groups considering the postoperative morbidity and mortality.</Para>
      </AbstractSection>
      <AbstractSection ID="ASec4">
        <Heading>Conclusion</Heading>
        <Para>Higher radiation doses and more use of simultaneous cisplatin lead to higher pathologic response rates to N-RCT and may be associated with better survival outcomes. Prospective controlled trials are needed to assess the true value of intensified N-RCT regimens.</Para>
      </AbstractSection>
    </Abstract>
    <Abstract ID="Abs2" Language="De" OutputMedium="All">
      <Heading>Zusammenfassung</Heading>
      <AbstractSection ID="ASec5">
        <Heading>Hintergrund</Heading>
        <Para>Wir stellen die Ergebnisse von Patienten mit Plattenepithelzellkarzinomen des Ösophagus (ESCC) vor, welche an unserem Institut mit neoadjuvanter Radiochemotherapie (N-RCT) mit Cisplatin und/oder 5-Fluorouracil (5-FU)  plusanschließender Operation behandelt worden sind.</Para>
      </AbstractSection>
      <AbstractSection ID="ASec6">
        <Heading>Patienten und Methodik</Heading>
        <Para>Wir haben retrospektiv die Daten jener Patienten analysiert, welche sich in unserer Abteilung zur N-RCT vorstellten. Von 1988 bis 2011 wurden 103 Patienten mit N-RCT behandelt. Gruppe 1: Von 1988 bis 2006 mit 39,6–40 Gy und 5-FU (n = 55), mit (n = 17) oder ohne Cisplatin (n = 38). Gruppe 2: Von 2003 bis 2010 mit 44–45 Gy und 5-FU mit (n = 40) oder ohne Cisplatin (n = 8). An allen Patienten wurden anschließend eine radikale Resektion des Ösophagus mit einer der Lokalisation entsprechenden Rekonstruktion und eine 2-Felder-Lymphdissektion vollzogen. Die histomorphologische Remission wurde wie folgt klassifiziert: Grad 1a (komplette Remission, 0 % Resttumor), Grad 1b (partielle/subtotale Remission, &lt; 10 % Resttumor), Grad 2 (10–50 % Resttumor) und Grad 3 (&gt; 50 % Resttumor).</Para>
      </AbstractSection>
      <AbstractSection ID="ASec7">
        <Heading>Ergebnisse</Heading>
        <Para>Die mediane Nachbeobachtungszeit seit Beginn der N-RCT lag bei 100 Monaten (Intervall 2–213 Monate). Die mediane Gesamtüberlebenszeit (OS) für das gesamte Kollektiv betrug 42 Monate bei einer 5-Jahres-Überlebensrate von 45 ± 5 %. In der multivarianten Analyse waren ein schlechterer ECOG-Performance-Status (p &lt; 0,001), ein Gewichtsverlust über 10 % vor Beginn der N-RCT (p = 0,025), ein höherer pT-Status (p = 0,001) und eine pathologische Remission 2./3. Grades (p &lt; 0,015) signifikant mit einem schlechteren OS assoziiert. Eine pathologisch komplette Remission (0 % Resttumor) bzw. subtotale Tumorregression (&lt; 10 % Resttumor) konnten bei 36 % bzw. 18 % der Patienten in Gruppe 1 und bei 55 % bzw. 22 % der Patienten in Gruppe 2 erreicht werden (p = 0,011). Insgesamt gab es die Tendenz für ein besseres Ergebnis für Patienten der Gruppe 2, welche jedoch statistisch nicht signifikant war. Die 5-Jahres-Gesamtüberlebensraten, krankheitsfreies Überleben und rezidivfreies Überleben in Gruppe 1 waren 36 ± 7 %, 35 ± 6 und 36 ± 7 % bzw. 55 ± 7, 49 ± 7 und 53 ± 7 in Gruppe 2 (p = 0,117, p = 0,124 und p = 0,087). Bezüglich der postoperativen Morbidität und Mortalität gab es keinen signifikanten Unterschied zwischen den beiden Gruppen.</Para>
      </AbstractSection>
      <AbstractSection ID="ASec8">
        <Heading>Schlussfolgerung</Heading>
        <Para>Eine intensivere N-RCT führte zu einer höheren kompletten Remissionsrate. Kontrollierte randomisierte Studien sind nötig, um zu beurteilen, ob intensivierte N-RCT-Konzepte die Ergebnisse von Patienten mit ESCC verbessern können.</Para>
      </AbstractSection>
    </Abstract>
    <KeywordGroup Language="En">
      <Heading>Keywords</Heading>
      <Keyword>Squamous cell carcinoma</Keyword>
      <Keyword>Esophagus</Keyword>
      <Keyword>Trimodality treatment</Keyword>
      <Keyword>Cisplatin</Keyword>
      <Keyword>Fluorouracil</Keyword>
    </KeywordGroup>
    <KeywordGroup Language="De">
      <Heading>Schlüsselwörter</Heading>
      <Keyword>Plattenepithelkarzinom</Keyword>
      <Keyword>Ösophagus</Keyword>
      <Keyword>Trimodale Therapie</Keyword>
      <Keyword>Cisplatin</Keyword>
      <Keyword>Fluorouracil</Keyword>
    </KeywordGroup>
  </ArticleHeader>
  <Body>
    <Para>Squamous cell carcinoma of the esophagus (ESCC) is a highly aggressive disease, with less than 15 % of all patients expected to survive beyond 10 years after diagnosis [<CitationRef CitationID="CR1">1</CitationRef>, <CitationRef CitationID="CR2">2</CitationRef>]. Several factors contribute to this poor outcome, the most important of which is that the vast majority of patients present with either locally advanced or metastatic disease at the time of diagnosis. Surgical resection (SR), radiochemotherapy (RCT) and the combination of these are the curative treatment options for ESCC. Due to poor results after surgery alone, attempts to improve the outcome with multimodal treatment (MMT) were suggested as early as the 1940s [<CitationRef CitationID="CR3">3</CitationRef>−<CitationRef CitationID="CR5">5</CitationRef>], indeed with encouraging results, leading the authors to comment: “The resectability rate was improved over that in the first series in which no preoperative radiation was used. The mortality was lowered from 56 to 14 %. The number of two-year survivors increased” [<CitationRef CitationID="CR3">3</CitationRef>]. Since then, MMT has advanced considerably. Improved radiotherapy techniques, employment of concomitant chemotherapy and better perioperative care have led to better outcomes. Several retrospective studies [<CitationRef CitationID="CR6">6</CitationRef>, <CitationRef CitationID="CR7">7</CitationRef>], prospective randomized trials [<CitationRef CitationID="CR8">8</CitationRef>, <CitationRef CitationID="CR9">9</CitationRef>] and meta-analyses [<CitationRef CitationID="CR10">10</CitationRef>–<CitationRef CitationID="CR15">15</CitationRef>] have shown the superiority of MMT over surgery alone [<CitationRef CitationID="CR16">16</CitationRef>].</Para>
    <Para>Considering the encouraging results of the CROSS study, MMT is now the preferred approach for the management of ESCC compared to surgery alone. The study regimen involves a radiation dose of 41.4 Gy combined with weekly paclitaxel and carboplatin [<CitationRef CitationID="CR8">8</CitationRef>]. However, the impact of different treatment modalities or neoadjuvant RCT (N-RCT) combinations on outcome remains undefined. Radiotherapy doses between 30 and 50.4 Gy [<CitationRef CitationID="CR9">9</CitationRef>, <CitationRef CitationID="CR17">17</CitationRef>–<CitationRef CitationID="CR20">20</CitationRef>] with different concomitant or induction chemotherapy regimens such as 5-fluorouracil (5-FU) alone, cisplatin/5-FU [<CitationRef CitationID="CR9">9</CitationRef>, <CitationRef CitationID="CR18">18</CitationRef>], carboplatin/paclitaxel [<CitationRef CitationID="CR8">8</CitationRef>], oxaliplatin/5-FU [<CitationRef CitationID="CR19">19</CitationRef>], etoposide/cisplatin [<CitationRef CitationID="CR20">20</CitationRef>], and many others are used at different institutions, with different results. This study was performed to report the outcomes of ESCC patients who were treated with N-RCT with curative intent in a single center with a high case load, and to identify factors that influenced the outcomes.</Para>
    <Section1 ID="Sec1">
      <Heading>Patients and methods</Heading>
      <Section2 ID="Sec2">
        <Heading>Patient population</Heading>
        <Para>We searched the registry of our department<?oxy_insert_start?> <?oxy_insert_end?><?oxy_insert_start?>at Klinikum rechts der Isar, Technische Universität München <?oxy_insert_end?>f<?oxy_comment_start comment="&lt;&lt;Please add comma after &quot;München&quot;&gt;&gt;&gt;"?>or<?oxy_comment_end?> all cases of ESCC treated with N-RCT with curative intent. From 1988 to 2011, 311 patients with ESCC were referred to our department for N-RCT. In the late 1980s and early 1990s, 114 patients were treated with 30 Gy and concomitant 5-FU. These patients were excluded from this analysis as this is an outdated N-RCT regimen with an inadequate radiation dose. Forty-one patients were treated with oxaliplatin-based N-RCT. The outcome of these two groups of patients has been reported elsewhere [<CitationRef CitationID="CR18">18</CitationRef>, <CitationRef CitationID="CR19">19</CitationRef>, <CitationRef CitationID="CR21">21</CitationRef>, <CitationRef CitationID="CR22">22</CitationRef>]. A total of 156 patients were referred to our department for N-RCT with 40–45 Gy and concomitant cisplatin and/or 5-FU. Of these 156 patients, 53were excluded as the MMT had to be switched to definitive RCT during or after N-RCT due to patientsʼ refusal, tumor progression, new findings (i.e., distant metastases) and tumor boardʼs conclusion after restaging (R0 resection unlikely). Outcomes of these 53 patients are subject of another publication in preparation. A total of 103 patients were treated with N-RCT during this period and were included in the study. The patients’ characteristics are summarized in Table <InternalRef RefID="Tab1">1</InternalRef>.</Para>
        <Para>
          
            <Table ID="Tab1" Float="Yes">
              <Caption Language="En">
                <CaptionNumber>Table 1</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Characteristics of the whole cohort and the two institutional treatment protocols</SimplePara>
                </CaptionContent>
              </Caption><tgroup cols="5">
              <colspec colnum="1" colname="c1" align="left" colwidth="22.74"/>
              <colspec colnum="2" colname="c2" align="left" colwidth="19.72"/>
              <colspec colnum="3" colname="c3" align="left" colwidth="19.02"/>
              <colspec colnum="4" colname="c4" align="left" colwidth="19.02"/>
              <colspec colnum="5" colname="c5" align="left" colwidth="19.49"/>
              <thead>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Characteristics</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>All patients</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>Group 1</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>Group 2</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>P value</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>n = 103</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>n = 55</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>n = 48</SimplePara>
                  </entry>
                </row>
              </thead>
              <tbody>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Age, median (range), years</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>59 (29–76)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>60 (29–76)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>57 (33–76)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5">
                    <SimplePara>&lt; 0.001</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Gender, n (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c2"/>
                  <entry align="left" colname="c3"/>
                  <entry align="left" colname="c4"/>
                  <entry align="left" colname="c5">
                    <SimplePara>0.405</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Female</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>28 (27)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>16 (29)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>12 (27)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Male</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>75 (73)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>39 (71)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>36 (73)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Clinical stage<Superscript>a</Superscript>, n (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c2"/>
                  <entry align="left" colname="c3"/>
                  <entry align="left" colname="c4"/>
                  <entry align="left" colname="c5">
                    <SimplePara>0.557</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>2</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>13 (13)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>8 (15)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>5 (10)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>3</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>89 (86)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>47 (85)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>42 (88)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>4a</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>1 (1)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>ECOG-PS, n (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c2"/>
                  <entry align="left" colname="c3"/>
                  <entry align="left" colname="c4"/>
                  <entry align="left" colname="c5">
                    <SimplePara>0.540</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>0–1</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>93 (90)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>50 (91)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>43 (90)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>2</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>10 (10)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>5 (9)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>5 (10)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Grading, n (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c2"/>
                  <entry align="left" colname="c3"/>
                  <entry align="left" colname="c4"/>
                  <entry align="left" colname="c5">
                    <SimplePara>0.153</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>G1–2</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>44 (43)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>20 (36)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>24 (50)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>G3–4</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>56 (54)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>32 (58)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>24 (50)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Unknown</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>3 (3)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>3 (6)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Weight loss, n (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c2"/>
                  <entry align="left" colname="c3"/>
                  <entry align="left" colname="c4"/>
                  <entry align="left" colname="c5">
                    <SimplePara>0.340</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>&lt; 10 %</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>76 (74)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>42 (76)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>34 (71)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>≥ 10 %</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>27 (26)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>13 (24)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>14 (29)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Location, n (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c2"/>
                  <entry align="left" colname="c3"/>
                  <entry align="left" colname="c4"/>
                  <entry align="left" colname="c5">
                    <SimplePara>0.291</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Upper thoracic</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>9 (9)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>7 (13)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>2 (4)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Mid thoracic</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>27 (26)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>14 (26)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>13 (27)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Lower thoracic</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>14 (14)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>5 (9)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>9 (19)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Overlapping</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>53 (52)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>29 (53)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>24 (50)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Length, n (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c2"/>
                  <entry align="left" colname="c3"/>
                  <entry align="left" colname="c4"/>
                  <entry align="left" colname="c5">
                    <SimplePara>0.395</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>≤ 8 cm</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>90 (87)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>49 (89)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>41 (85)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>&gt; 8 cm</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>13 (13)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>6 (11)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>7 (15)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5"/>
                </row>
              </tbody></tgroup><tfooter>
                
                  <SimplePara><Emphasis Type="Italic">PS</Emphasis> performance status, <Emphasis Type="Italic">y</Emphasis> years, <Emphasis Type="Italic">RT</Emphasis> radiotherapy, <Emphasis Type="Italic">n</Emphasis> number</SimplePara>
                
                
                  <SimplePara><Superscript>a</Superscript>According to UICC 2002 (6th edition).</SimplePara>
                
              </tfooter></Table>
          
        </Para>
        <Para>As this was a retrospective review, selection of the chemotherapeutic regimen patients received was not randomized or stratified. Higher radiation doses and concomitant cisplatin-based radiosensitizing chemotherapy were gradually established as our standard institutional protocol during the years. Initially, patients with ESCC were treated with N-RCT that consisted of 30 Gy and concomitant continuous infusional 5-FU at our institution. Considering the published literature at that time, we increased step by step the radiation dose and established cisplatin as an additional radiosensitizing agent. Therefore one of the most important factors influencing which regimen was selected is the time period, but also patient’s and physician’s preference. The staging evaluation included complete history, physical examination, serum chemistry profile, complete blood count, chest X-ray, barium swallow (in the early 1990s), esophagogastroduodenoscopy with biopsy, endosonography, computed tomography (CT) of the neck, chest and abdomen, abdominal ultrasound, and cardiopulmonary function tests (to evaluate the medical operability). PET-CT was performed in 40 patients (39 %). Panendoscopy was performed to rule out simultaneous head and neck cancer, and bronchoscopy was performed in patients with middle and upper third tumors to exclude tracheobronchial invasion. Toxicity was assessed retrospectively according to CTC version 3.0. Two patients died 2–3 weeks after N-RCT due to pneumonia (n = 1) and cardiac arrest (n = 1). Both events were considered as grade V acute toxicity. These two patients were excluded from analyses evaluating pCR or resection status.</Para>
      </Section2>
      <Section2 ID="Sec3">
        <Heading>Treatment</Heading>
        <Section3 ID="Sec4">
          <Heading>Neoadjuvant radiochemotherapy</Heading>
          <FormalPara RenderingStyle="Style1">
            <Heading>RT technique</Heading>
            <Para>Conformal external-beam radiotherapy with 6–15 MeV photons was delivered using 3- and 4-field techniques. The clinical target volume (CTV) comprised the primary tumor with a margin of 4 cm in the craniocaudal direction and regional lymph nodes. The margin of the planning target volume to the CTV was 8–10 mm in all directions, taking internal organ movements as well as setup errors into account.</Para>
          </FormalPara>
          <Para>Considering the radiation dose and the concomitant chemotherapy regimens, patients were divided into two different groups:</Para>
          <Para>Group1: Patients treated from 1991–2006: N-RCT consisted of 39.6–40 Gy (range 1.8–2 Gy per fraction; n = 55) with 5-FU (300 mg/m<Superscript>2</Superscript>/day) concomitant to radiotherapy, with (n = 17) or without cisplatin (n = 38), (25–30 mg/m<Superscript>2</Superscript>/day on days 1, 8, 15 and 22).</Para>
          <Para>Group 2: Patients treated from 2003–2010: N-RCT consisted of 44–45 Gy (range 1.8–2 Gy per fraction; n = 48). Concomitant chemotherapy consisted of continuous infusion of 5-FU (500 mg/m<Superscript>2</Superscript>/day on days 1–5 and 29–33) with (n = 40) or without cisplatin (n = 8) (20 mg/m<Superscript>2</Superscript>/day on days 1–5 and 29–33).</Para>
        </Section3>
      </Section2>
      <Section2 ID="Sec5">
        <Heading>Restaging</Heading>
        <Para>Three to four weeks after the completion of the neoadjuvant treatment, the effects of RCT on the primary tumor and metastatic nodes were assessed using chest CT scanning and gastrointestinal endoscopy with or without endoluminal ultrasound. Esophagectomy was performed at 4–6 weeks after the completion of RCT.</Para>
      </Section2>
      <Section2 ID="Sec6">
        <Heading>Surgical resection</Heading>
        <Para>All patients underwent radical resections according to the primary tumor location approximately 4–6 weeks after the last day of N-RCT with radical lymphadenectomy in a high-volume department. Tumors located in the distal or middle part of the esophagus were treated by abdominothoracic resection with gastric pull-up and intrathoracic anastomosis (Ivor–Lewis). Lesions above the bifurcation were treated by thoracic resection of the esophagus and reconstruction primarily with a gastric pull-up and a cervical anastomosis or a colon interposition with cervical anastomosis [<CitationRef CitationID="CR23">23</CitationRef>]. Cervical esophageal cancer patients underwent cervical resections reconstructed by a free jejunal interposition with microvascular anastomosis. In patients with a high risk score, a two-stage approach was applied, starting with the esophageal resection and a cervical stoma, followed by the retrosternal pull-up of a gastric tube or colon interposition applied 1–2 weeks after the first operation.</Para>
      </Section2>
      <Section2 ID="Sec7">
        <Heading>Pathological analysis</Heading>
        <Para>The tumor stage was defined according to the classification of the UICC 2002 [<CitationRef CitationID="CR24">24</CitationRef>]. To grade the response to N-RCT, the degree of histomorphologic regression was classified as described by Becker et al. [<CitationRef CitationID="CR25">25</CitationRef>] into the following four categories: complete regression (pCR: 0 % residual tumor; grade 1a), subtotal tumor regression (pSTR: &lt; 10 % residual tumor per tumor bed; grade 1b), partial tumor regression (10–50 % residual tumor per tumor bed; grade 2), and minimal or no tumor regression (&gt; 50 % residual tumor per tumor bed; grade 3). If a vital tumor was present 1 mm or less from the proximal, distal or circumferential resection margin, it was considered microscopically positive (R1). If the surgeon reported an unresectable residual macroscopic tumor, it was considered an R2 resection. If presence of residual tumor could not be assessed it was considered an Rx.</Para>
      </Section2>
      <Section2 ID="Sec8">
        <Heading>Follow-up</Heading>
        <Para>During the first year after treatment was completed, patients were seen every 3 months. In the second year, follow-up took place every 6 months, and then annually. During follow-up, diagnostic investigations including CT and endoscopy were performed up to 5 years, and thereafter only when recurrence was suspected.</Para>
      </Section2>
      <Section2 ID="Sec9">
        <Heading>Statistical methods</Heading>
        <Para>Overall survival (OS), disease-free survival (DFS), and recurrence-free survival (RFS) were analyzed according to the Kaplan–Meier method. Survival curves between independent subgroups were compared by the log-rank test. To adjust for potentially confounding factors, multivariable Cox proportional hazard regression models were employed. The cumulative incidence function for time to metastasis and time to local recurrence, considering death as a competing risk, was estimated using the library <Emphasis Type="Italic">cmprsk</Emphasis> of the statistical software R, ver. 2.15.1. Comparison of cumulative incidence functions was performed using Gray’s test. A two-sided level of significance of α = 5 % was used for all statistical tests.</Para>
      </Section2>
    </Section1>
    <Section1 ID="Sec10">
      <Heading>Results</Heading>
      <Para>A total of 101 patients underwent surgical resection. R0, R1, and Rx resections were achieved in 89 (88 %), 6 (6 %), and 4 (4 %) patients, respectively. In 2 patients (2 %) the surgeon reported an R2 resection. We observed pCR in 44 % of the patients, pSTR in 20 %, partial tumor regression in 18 % and no response to N-RCT in 15 %. In 4 % the regression grade was not reported. Down-staging in T- and N-categories was observed in 75 % and 65 %, respectively. In 1 % of patients, a higher pT-category was diagnosed as the initial diagnostic work-up had suggested.</Para>
      <Section2 ID="Sec11">
        <Heading>Outcomes of the whole cohort</Heading>
        <Para>Median follow-up time from the start of N-RCT was 100 months (range 2–213 months). OS at 2, 5, and 10 years was 62 ± 5 %, 45 ± 5 %, and 34 ± 6 %, respectively, with a median OS time of 42 months (95 % CI 25–58 months). DFS at 2, 5, and 10 years was 53 ± 5 %, 41 ± 5 %, and 32 ± 5 %, respectively. RFS at 2, 5, and 10 years was 55 ± 5 %, 44 ± 5 %, and 35 ± 5 %, respectively (Fig. <InternalRef RefID="Fig1">1</InternalRef>). In 22 patients (21 %), distant metastases were diagnosed after a median time of 13 months (range 2–51 months). The most common site of distant metastasis was the lung (n = 10, 10 %) followed by nonregional lymph nodes (n = 8, 8 %), liver (n = 7, 7 %) and bone (n = 6, 6 %). The prevalence of distant metastasis tended to be lower in patients who received concomitant cisplatin compared to those receiving 5-FU alone (16 % vs. 29 %, p = 0.091). Locoregional recurrence was observed in a total of 23 patients (22 %); in 16 of these patients (70 %) the recurrence was within the irradiated volume (in-field recurrence). Estimated 2-year cumulative incidence probability for locoregional recurrence and distant metastasis was 19 ± 4 % and 16 ± 4 % for the whole cohort, respectively. Estimated 2-year cumulative incidence probability for distant metastasis was 12 ± 4 % for patients who received cisplatin ± 5-FU and 19 ± 6 % for patients who received 5-FU only (p = 0.054).</Para>
        <Para>
          <Figure ID="Fig1" Float="Yes" Category="Standard">
            <Caption Language="En">
              <CaptionNumber>Fig. 1</CaptionNumber>
              <CaptionContent>
                <SimplePara>OS, DFS and RFS of whole cohort</SimplePara>
              </CaptionContent>
            </Caption>
            <MediaObject>
              <ImageObject Type="Linedraw" Rendition="HTML" Format="GIF" FileRef="66_2014_711_Fig1_HTML.gif" Color="BlackWhite"/>
            </MediaObject>
          </Figure>
        </Para>
      </Section2>
      <Section2 ID="Sec12">
        <Heading>Results of univariate and multivariate analyses</Heading>
        <Para>Results of the univariate analyses for OS, DFS, and RFS are displayed in Table <InternalRef RefID="Tab2">2</InternalRef>. In the univariate analysis, weight loss prior to N-RCT, ECOG performance status, administration of cisplatin, resection status, histopathologic regression, pT category and pN category were significantly associated with OS, RFS, and DFS and were included in the multivariate analysis.</Para>
        <Para>
          
            <Table ID="Tab2" Float="Yes">
              <Caption Language="En">
                <CaptionNumber>Table 2</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Results of the univariate analysis for OS, RFS and DFS</SimplePara>
                </CaptionContent>
              </Caption><tgroup cols="9">
              <colspec colnum="1" colname="c1" align="left" colwidth="11.84"/>
              <colspec colnum="2" colname="c2" align="left" colwidth="11.84"/>
              <colspec colnum="3" colname="c3" align="left" colwidth="11.84"/>
              <colspec colnum="4" colname="c4" align="left" colwidth="11.84"/>
              <colspec colnum="5" colname="c5" align="left" colwidth="11.84"/>
              <colspec colnum="6" colname="c6" align="left" colwidth="11.84"/>
              <colspec colnum="7" colname="c7" align="left" colwidth="11.84"/>
              <colspec colnum="8" colname="c8" align="left" colwidth="11.84"/>
              <colspec colnum="9" colname="c9" align="left" colwidth="5.30"/>
              <thead>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Factor</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>Group</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>n</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>5-year OS (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c5">
                    <SimplePara>P value</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>5-y<?oxy_insert_start?>e<?oxy_insert_end?>ar RFS (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c7">
                    <SimplePara>P value</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>5-year DFS (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c9">
                    <SimplePara>P value</SimplePara>
                  </entry>
                </row>
              </thead>
              <tbody>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Gender</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>Male</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>75</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>43 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.524</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>43 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.708</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>41 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.829</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Female</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>28</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>49 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>46 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>43 ± 9</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Age</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>&lt; 59 years</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>50</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>46 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.597</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>46 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.561</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>44 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.510</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>≥ 59 years</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>53</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>44 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>42 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>39 ± 7</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>ECOG-PS</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>0–1</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>93</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>49 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>&lt; 0.001</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>48 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>&lt; 0.001</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>45 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>&lt; 0.001</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>2</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>10</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>10 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>10 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>10 ± 10</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Weight loss</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>&lt; 10 %</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>76</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>50 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.012</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>49 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.018</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>45 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.046</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>≥ 10 %</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>27</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>30 ± 9</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>30 ± 9</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>30 ± 9</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Length</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>≤ 8 cm</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>90</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>46 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.302</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>45 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.181</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>43 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.097</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>&gt; 8 cm</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>13</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>39 ± 14</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>39 ± 14</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>31 ± 13</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="3">
                    <SimplePara>Location</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>Upper thoracal</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>9</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>67 ± 16</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="3">
                    <SimplePara>0.265</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>67 ± 16</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="3">
                    <SimplePara>0.255</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>67 ± 16</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="3">
                    <SimplePara>0.203</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Mid thoracal</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>27</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>48 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>48 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>48 ± 10</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Lower thoracal</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>14</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>43 ± 13</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>43 ± 13</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>36 ± 13</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Overlapping</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>53</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>40 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>38 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>35 ± 7</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Grade</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>G1/2</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>44</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>51 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.234</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>49 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.220</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>45 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.268</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>G3/4</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>56</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>39 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>39 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>37 ± 7</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>cT status</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>T1/T2</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>8</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>45 ± 19</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.622</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>35 ± 11</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.859</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>47 ± 19</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.564</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>T3/T4</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>95</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>45 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>37 ± 3</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>41 ± 5</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>cN status</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>N0</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>7</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>57 ± 19</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.402</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>57 ± 19</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.361</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>57 ± 19</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.288</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>N +</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>96</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>44 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>43 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>40 ± 5</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>PET-CT</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>Yes</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>40</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>49 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.559</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>49 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.418</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>47 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.421</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>No</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>63</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>42 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>41 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>38 ± 6</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Cisplatin</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>Yes</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>57</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>57 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="1">
                    <SimplePara>0.007</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>55 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="1">
                    <SimplePara>0.005</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>50 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="1">
                    <SimplePara>0.006</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara><?oxy_delete content="≥ 59"?><?oxy_insert_start?>No<?oxy_insert_end?></SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>46</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>29 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>29 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>29 ± 7</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="3">
                    <SimplePara>pT status</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>T0/T1</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>50</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>67 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="3">
                    <SimplePara>0.001</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>65 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="3">
                    <SimplePara>0.001</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>61 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="3">
                    <SimplePara>&lt; 0.001</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>T2</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>21</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>33 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>33 ± 10</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>33 ± 10</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>T3/T4</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>27</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>19 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>19 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>15 ± 7</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Unknown</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>3</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>33 ± 27</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>33 ± 27</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>33 ± 27</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="2">
                    <SimplePara>pN status</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>N0</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>72</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>57 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="2">
                    <SimplePara>0.012</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>55 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="2">
                    <SimplePara>0.010</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>52 ± 6</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="2">
                    <SimplePara>0.004</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>N +</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>25</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>17 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>18 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>16 ± 7</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Unknown</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>4</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="3">
                    <SimplePara>P. regression. grade</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>1a</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>44</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>65 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="3">
                    <SimplePara>0.006</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>63 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="3">
                    <SimplePara>0.005</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>58 ± 8</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="3">
                    <SimplePara>0.004</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>1b</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>20</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>50 ± 11</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>50 ± 11</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>44 ± 11</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Non resp.</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>33</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>21 ± 7</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>21 ± 7</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>Unknown</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>4</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>25 ± 12</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1" morerows="2">
                    <SimplePara>R status</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>89</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>51 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c5" morerows="2">
                    <SimplePara>0.004</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>50 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c7" morerows="2">
                    <SimplePara>0.004</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>47 ± 5</SimplePara>
                  </entry>
                  <entry align="left" colname="c9" morerows="2">
                    <SimplePara>0.010</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>1</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>8</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>0 ± 0</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>0 ± 0</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>0 ± 0</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>X</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>4</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                  <entry align="left" colname="c6">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                  <entry align="left" colname="c8">
                    <SimplePara>25 ± 22</SimplePara>
                  </entry>
                </row>
              </tbody></tgroup><tfooter>
                
                  <SimplePara><Emphasis Type="Italic">c</Emphasis> clinical, <Emphasis Type="Italic">p</Emphasis> pathological, <Emphasis Type="Italic">n</Emphasis> number, <Emphasis Type="Italic">OS</Emphasis> overall survival, <Emphasis Type="Italic">DFS</Emphasis> disease-free survival, <Emphasis Type="Italic">RFS</Emphasis> recurrence-free survival.</SimplePara>
                
              </tfooter></Table>
          
        </Para>
        <Para>In the multivariate analysis, poorer ECOG performance status (ECOG 2 vs. ECOG 0–1: HR 4.420, p &lt; 0.001), weight loss before start of the N-RCT (&gt; 10 % vs. ≤ 10 %: HR 2.108, p = 0.025), higher pT category (pT3–4 vs. pT2: HR 2.570, p = 0.007; pT3–4 vs. pT0–1: HR 3.269, p = 0.001), and regression grade 2–3 (grade 2–3 vs. grade 1a: HR 3.039, p &lt; 0.001, grade 2–3 vs. grade 1b: HR 1.570, p = 0.070) were significantly associated with a poor OS.</Para>
      </Section2>
      <Section2 ID="Sec13">
        <Heading>Outcomes of the two different regimens</Heading>
        <Para>To detect any differences between the outcomes of our two different N-RCT institutional modalities, we performed a subgroup analysis. The pCR and pSTR rates for group 1 were 36 % and 18 % compared to 53 % and 22 % for group 2 (p = 0.011). R0 resection was achieved in 91 % of group 1 and 94 % of group 2 (p = 0.434). There was a tendency for a better outcome in group 2 patients without reaching statistical significance. The 5-year OS (Fig. <InternalRef RefID="Fig2">2</InternalRef>), DFS, and RFS were 36 ± 7 %, 35 ± 6, and 36 ± 7 % for group 1 and 55 ± 7, 49 ± 7, and 53 ± 7 in group 2, respectively (p = 0.117, p = 0.124 and p = 0.087).</Para>
        <Para>
          <Figure ID="Fig2" Float="Yes" Category="Standard">
            <Caption Language="En">
              <CaptionNumber>Fig. 2</CaptionNumber>
              <CaptionContent>
                <SimplePara>OS considering the two different groups of N-RCT</SimplePara>
              </CaptionContent>
            </Caption>
            <MediaObject>
              <ImageObject Type="Linedraw" Rendition="HTML" Format="GIF" FileRef="66_2014_711_Fig2_HTML.gif" Color="BlackWhite"/>
            </MediaObject>
          </Figure>
        </Para>
      </Section2>
      <Section2 ID="Sec14">
        <Heading>Toxicities and complications</Heading>
        <Para>Two patients died before surgery; one patient had received 45 Gy + cisplatin/5-FU and one 45 Gy + 5-FU. Two patients died during the first month after surgery, both were treated with 40 Gy (group 1). The most common nonhematologic and hematologic &gt; grade 2 acute toxicity of the N-RCT prior to SR and most common postoperative complication after SR were dysphagia (19 %), neutropenia (9 %), and pneumonia (19 %), respectively. There was no significant difference between the two groups considering the acute toxicities. The preoperative acute sequelae of the N-RCT and the postoperative complications are displayed in the Tables <InternalRef RefID="Tab3">3</InternalRef> and <InternalRef RefID="Tab4">4</InternalRef>.</Para>
        <Para>
          
            <Table ID="Tab3" Float="Yes">
              <Caption Language="En">
                <CaptionNumber>Table 3</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Acute toxicity grade ≥ 3 after N-RCT</SimplePara>
                </CaptionContent>
              </Caption><tgroup cols="4">
              <colspec colnum="1" colname="c1" align="left" colwidth="30.78"/>
              <colspec colnum="2" colname="c2" align="left" colwidth="31.14"/>
              <colspec colnum="3" colname="c3" align="left" colwidth="19.05"/>
              <colspec colnum="4" colname="c4" align="left" colwidth="19.03"/>
              <thead>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Acute toxicities grade ≥ 3</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>All patients</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>Group 1</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>Group 2</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>103 (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>55 (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>48 (%)</SimplePara>
                  </entry>
                </row>
              </thead>
              <tbody>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Nonhematologic</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>34 (33)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>17 (31)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>17 (35)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Hoarseness</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>22 (10)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>3 (6)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>4 (8)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Dysphagia</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>20 (19)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>9 (16)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>11 (23)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Esophagitis and mucositis</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>13 (13)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>8 (15)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>4 (8)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Nausea</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>3 (3)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>2 (4)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Abscess</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>2 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>2 (4)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Cough</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>2 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>2 (4)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Creatinine</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>2 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Pulmonary symptoms</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>1 (1)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Severe fever</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>1 (1)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Hematologic</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>9 (9)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>4 (7)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>5 (10)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Neutropenia</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>9 (9)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>4 (7)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>5 (10)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Thrombocytopenia</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>2 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                </row>
              </tbody></tgroup></Table>
          
        </Para>
        <Para>
          
            <Table ID="Tab4" Float="Yes">
              <Caption Language="En">
                <CaptionNumber>Table 4</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Surgery-related complications</SimplePara>
                </CaptionContent>
              </Caption><tgroup cols="4">
              <colspec colnum="1" colname="c1" align="left" colwidth="34.73"/>
              <colspec colnum="2" colname="c2" align="left" colwidth="25.37"/>
              <colspec colnum="3" colname="c3" align="left" colwidth="19.96"/>
              <colspec colnum="4" colname="c4" align="left" colwidth="19.94"/>
              <thead>
                <row>
                  <entry align="left" colname="c1" morerows="1">
                    <SimplePara>Surgical complications</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>All patients</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>Group 1</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>Group 2</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c2">
                    <SimplePara>101 (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>46 (%)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>55 (%)</SimplePara>
                  </entry>
                </row>
              </thead>
              <tbody>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Pneumonia</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>19 (19)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>8 (17)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>11 (20)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Wound infection</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>17 (17)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>8 (17)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>9 (16)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Vocal cord paresis</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>11 (11)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>4 (9)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>4 (7)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Clinical AL<Superscript>a</Superscript></SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>5 (5)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>3 (7)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>2 (4)</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>DVT/PE</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>2 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>2 (4)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>0</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>SVT</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>2 (2)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>2 (4)</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>0</SimplePara>
                  </entry>
                </row>
                <row>
                  <entry align="left" colname="c1">
                    <SimplePara>Severe fever</SimplePara>
                  </entry>
                  <entry align="left" colname="c2">
                    <SimplePara>1 (1)</SimplePara>
                  </entry>
                  <entry align="left" colname="c3">
                    <SimplePara>0</SimplePara>
                  </entry>
                  <entry align="left" colname="c4">
                    <SimplePara>1 (2)</SimplePara>
                  </entry>
                </row>
              </tbody></tgroup><tfooter>
                
                  <SimplePara><Emphasis Type="Italic">AL</Emphasis> anastomotic leak, <Emphasis Type="Italic">SVT</Emphasis> supraventricular tachycardia or atrial fibrillation, <Emphasis Type="Italic">DVT/PE</Emphasis> deep vein thrombosis or pulmonary embolism requiring anticoagulation</SimplePara>
                
                
                  <SimplePara><Superscript>a</Superscript>Clinical anastomotic leak, which required surgical intervention.</SimplePara>
                
              </tfooter></Table>
          
        </Para>
      </Section2>
    </Section1>
    <Section1 ID="Sec15">
      <Heading>Discussion</Heading>
      <Para>We report on outcomes of a mono-institutional ESCC patient cohort undergoing N-RCT followed by resection with a long median follow-up time of more than 9 years. We observed better outcomes for patients who achieved pCR, which is in line with other studies [<CitationRef CitationID="CR10">10</CitationRef>, <CitationRef CitationID="CR14">14</CitationRef>, <CitationRef CitationID="CR26">26</CitationRef>]. N-RCT results in pCR rates between 10 and 49 % [<CitationRef CitationID="CR10">10</CitationRef>, <CitationRef CitationID="CR14">14</CitationRef>, <CitationRef CitationID="CR27">27</CitationRef>]. Recently, van Hagen et al. [<CitationRef CitationID="CR8">8</CitationRef>] reported pCR rates of 49 % after N-RCT in the subgroup of patients with ESCC in their randomized trial, CROSS, which is comparable to our series (44 % pCR). The slightly better pCR rate observed in the CROSS study may be due to the fact that 45 % of our patients were treated with 5-FU only as concomitant chemotherapy and therefore had probably received suboptimal radiosensitizing treatment. Of note, the pCR rate of our patients in group 2, who were treated with 45 Gy and cisplatin-based chemotherapy was as high as 52 %. Another important comparison is that in the CROSS study patients with longitudinal tumor length &gt; 8 cm and radial diameter &gt; 5 cm, inadequate caloric or fluid intake or weight loss &gt; 10 % were excluded, which might have led not only to a favorable group of patients but also to a selection of tumors with less aggressive biologic nature.</Para>
      <Para>The optimal radiation dose and concomitant chemotherapy for N-RCT is not easy to determine, as several controversial issues have to be considered. This issue is beyond the scope of this paper and has been discussed elsewhere [<CitationRef CitationID="CR28">28</CitationRef>–<CitationRef CitationID="CR30">30</CitationRef>]. However, if choosing the CROSS regimen, one should keep in mind that the efficacy of this combination has not been studied for patients with longitudinal tumor length &gt; 8 cm and radial &gt; 5 cm, inadequate caloric or fluid intake, or weight loss &gt; 10 %. Of note, in the daily routine a considerable number of patients with ESCC present with at least one or more of these criteria. If under these circumstances the CROSS regimen is optimal is currently unknown. In our study, 27 patients (26 %) had a weight loss of more than 10 % and another 9 patients (9 %) a tumor with a longitudinal length of &gt; 8 cm. In fact, more than one third of the patients in our cohort would have been excluded from the CROSS study. If we excluded these patients from our cohort the estimated 5-year OS of the group 2 patients would rise to 63 %. However, interstudy comparisons might always suffer from bias such as different inclusion criteria or staging protocols, especially when studies were performed during different time periods, or if one looks at a mixture of randomized and nonrandomized studies.</Para>
      <Para>The major limitation of our study is its retrospective design. The two patient groups contained at most 55 patients, resulting in limited statistical power, e.g., for survival comparisons. Therefore, the survival trends reported here should not be over-interpreted. The fact that for some overlapping periods of time, there was more than one treatment plan available at our institution, is not necessarily a limitation of this study. The strengths of our study include treatment at a high-volume center (more than 100 esophagectomies annually) and standardized evaluation of histopathologic specimens.</Para>
      <Para>One challenging, not uncommon situation for radiation oncologists is that after restaging 6–8 weeks after N-RCT, new findings or changed patient preferences impede the initially planned SR. In our cohort, N-RCT took the option of primary SR from 2 patients who died due to complications of N-RCT. However, one should note that between 5 and 35 % of patients with esophageal cancer who undergo N-RCT will not be operated at all due to different reasons [<CitationRef CitationID="CR31">31</CitationRef>]. At our institution this was the case in 33 % of patients, in whom the trimodality treatment had to be stopped or switched to definitive RCT. Patients in whom a second cycle of RCT had to be started because the SR could not be performed had significantly poorer median OS compared to patients in whom the decision to switch the N-RCT to definitive RCT was made during the N-RCT without the break for restaging (publication in preparation). Considering that the tumor cells have been treated with an insufficient (for definitive regimens) radiation dose, they might repopulate during the break for re-evaluation. An additional boost after this period of time is unlikely to result in long-term disease control or cure.</Para>
      <Para>Therefore, it might be crucial for improving the outcome of patients to consider several additional points before directing them in to an MMT with suboptimal definitive radiation doses. These should include patientsʼ compliance, accurate staging and evaluation of resectability of the tumor and especially no illusional expectations from N-RCT. The landmark CROSS study has ultimately shown that well-tailored trimodality treatment is superior to surgery alone. But, there are some hypothetical approaches for the curative treatment of esophageal cancer, which have to be evaluated in prospective randomized trials. For instance, the efficacy and feasibility of salvage surgical resection for those who do not adequately respond to modern definitive RCT with moderate doses (50.4–54 Gy) is an understudied but interesting approach.</Para>
      <Para>There are reports which indicate that N-RCT with moderate doses is not associated with higher morbidity and mortality compared to surgery alone. These reports identified presence of preoperative coronary artery disease, a transthoracic surgical approach, congestive heart failure and especially the experience of the individual surgeon, as well as esophagectomy at a high-volume esophageal surgery center as the crucial factors affecting the perioperative morbidity and mortality [<CitationRef CitationID="CR32">32</CitationRef>–<CitationRef CitationID="CR35">35</CitationRef>].</Para>
      <Section2 ID="Sec16">
        <Heading>Conclusion</Heading>
        <Para>One-third of patients with locally advanced ESCC who are treated with N-RCT and esophagectomy survive for more than a decade. In our series, higher neoadjuvant radiation doses and more use of cisplatin as a radiosensitizing agent led to higher pathologic response rates to N-RCT. Controlled prospective trials are needed to evaluate if intensified N-RCT regimens can definitely improve the outcomes of ESCC patients.</Para>
      </Section2>
    </Section1>
    
  </Body>
  <BodyRef OutputMedium="All" FileRef="66_2014_711_OnlinePDF.pdf" PDFType="Typeset" TargetType="OnlinePDF"/>
  <ArticleBackmatter>
    <Acknowledgments>
      <Heading>Compliance with ethical guidelines</Heading>
      <FormalPara RenderingStyle="Style1">
        <Heading>Conflict of interest</Heading>
        <Para>K. Fakhrian, A.D. Ordu, F. Lordick, J. Theisen, B. Haller, T. Omrčen, M. Molls, C. Nieder, and H. Geinitz have made no statement. The accompanying manuscript does not include studies on humans or animals.</Para>
      </FormalPara>
    </Acknowledgments>
    <Bibliography ID="Bib1">
      <Heading>References</Heading>
      <Citation ID="CR1">
        <CitationNumber>1.</CitationNumber><BibArticle>
  <BibAuthorName>
    <Initials>A</Initials>
    <FamilyName>Dubecz</FamilyName>
  </BibAuthorName>
  <BibAuthorName>
    <Initials>I</Initials>
    <FamilyName>Gall</FamilyName>
  </BibAuthorName>
  <BibAuthorName>
    <Initials>N</Initials>
    <FamilyName>Solymosi</FamilyName>
  </BibAuthorName>
  <Etal/>
  <Year>2012</Year>
  <ArticleTitle Language="En">Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis</ArticleTitle>
  <JournalTitle>J Thorac Oncol</JournalTitle>
  <VolumeID>7</VolumeID>
  <FirstPage>443</FirstPage>
  <LastPage>447</LastPage>
<Occurrence Type="DOI">
<Handle>10.1097/JTO.0b013e3182397751</Handle>
</Occurrence>
</BibArticle>
        <BibUnstructured>Dubecz A, Gall I, Solymosi N et al (2012) Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol 7:443–447</BibUnstructured>
      </Citation>
      <Citation ID="CR2">
        <CitationNumber>2.</CitationNumber><BibArticle>
  <BibAuthorName>
    <Initials>PC</Initials>
    <FamilyName>Enzinger</FamilyName>
  </BibAuthorName>
  <BibAuthorName>
    <Initials>RJ</Initials>
    <FamilyName>Mayer</FamilyName>
  </BibAuthorName>
  <Year>2003</Year>
  <ArticleTitle Language="En">Esophageal cancer</ArticleTitle>
  <JournalTitle>N Engl J Med</JournalTitle>
  <VolumeID>349</VolumeID>
  <FirstPage>2241</FirstPage>
  <LastPage>2252</LastPage>
<Occurrence Type="DOI">
<Handle>10.1056/NEJMra035010</Handle>
</Occurrence>
</BibArticle>
        <BibUnstructured>Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241–2252</BibUnstructured>
     </Citation>
            <Citation ID="CR3">
              <CitationNumber>3.</CitationNumber>
              <BibUnstructured>Bates, D.: Fitting linear mixed models. R News <Emphasis Type="Bold">5</Emphasis>, 27–30 (2005). <ExternalRef>
                  <RefSource>http://www.r-project.org/doc/Rnews/Rnews_2005-1.pdf</RefSource>
                  <RefTarget TargetType="URL" Address="http://www.r-project.org/doc/Rnews/Rnews_2005-1.pdf"/>
                </ExternalRef>
              </BibUnstructured>
            </Citation>
            <Citation ID="CR4">
              <CitationNumber>4.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>H.</Initials>
                  <FamilyName>Zuckerman</FamilyName>
                </BibAuthorName>
                <Year>1987</Year>
                <ArticleTitle xml:lang="en" Language="En">Citation analysis and the complex problem of intellectual influence</ArticleTitle>
                <JournalTitle>Scientometrics</JournalTitle>
                <VolumeID>12</VolumeID>
                <FirstPage>329</FirstPage>
                <LastPage>338</LastPage>
                <Occurrence Type="DOI">
                  <Handle>10.1007/BF0201667</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Zuckerman, H. (1987). Citation analysis and the complex problem of intellectual influence. <Emphasis Type="Italic">Scientometrics</Emphasis>, 12, 329–338.</BibUnstructured>
            </Citation>

    </Bibliography>
  </ArticleBackmatter>
  
					</Article>